Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation (original) (raw)

• DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11–20 (2008).
  Article CAS PubMed Google Scholar
• Le, A. et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110–121 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, P. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762–765 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782–18787 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101–105 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Roberts, E. et al. Amino acids in epidermal carcinogenesis in mice. Cancer Res. 9, 350–353 (1949).
  CAS PubMed Google Scholar
• Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75, 544–553 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Mosammaparast, N. & Shi, Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155–179 (2010).
  Article CAS PubMed Google Scholar
• Klose, R. J. & Zhang, Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8, 307–318 (2007).
  Article CAS PubMed Google Scholar
• Carey, B. W., Finley, L. W., Cross, J. R., Allis, C. D. & Thompson, C. B. Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518, 413–416 (2015).
  Article CAS PubMed Google Scholar
• Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• De Santa, F. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083–1094 (2007).
  Article CAS PubMed Google Scholar
• Seward, D. J. et al. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat. Struct. Mol. Biol. 14, 240–242 (2007).
  Article CAS PubMed Google Scholar
• Li, K. K., Luo, C., Wang, D., Jiang, H. & Zheng, Y. G. Chemical and biochemical approaches in the study of histone methylation and demethylation. Med. Res. Rev. 32, 815–867 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dewhirst, M. W., Cao, Y. & Moeller, B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 8, 425–437 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dankort, D. et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 41, 544–552 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, B. et al. Single-cell phenotyping within transparent intact tissue through whole-body clearing. Cell 158, 945–958 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Conti, F. & Minelli, A. Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase. J. Histochem. Cytochem. 42, 717–726 (1994).
  Article CAS PubMed Google Scholar
• Wang, J. B. et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18, 207–219 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Boiko, A. D. et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133–137 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Civenni, G. et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 71, 3098–3109 (2011).
  Article CAS PubMed Google Scholar
• Monzani, E. et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 43, 935–946 (2007).
  Article CAS PubMed Google Scholar
• Schatton, T. et al. Identification of cells initiating human melanomas. Nature 451, 345–349 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Erickson, S. L. et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124, 4999–5011 (1997).
  CAS PubMed Google Scholar
• Oetting, W. S. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Res. 13, 320–325 (2000).
  Article CAS PubMed Google Scholar
• Aoki, H., Tomita, H., Hara, A. & Kunisada, T. Conditional deletion of kit in melanocytes: white spotting phenotype is cell autonomous. J. Invest. Dermatol. 135, 1829–1838 (2015).
  Article CAS PubMed Google Scholar
• Kwon, B. S. et al. A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl Acad. Sci. USA 88, 9228–9232 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Sargiannidou, I. et al. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease. Ann. Neurol. 78, 303–316 (2015).
  Article CAS PubMed Google Scholar
• Mortl, M., Busse, D., Bartel, H. & Pohl, B. Partial purification and characterization of rabbit-kidney brush-border (Ca2 + or Mg2 +)-dependent adenosine triphosphatase. Biochim. Biophys. Acta 776, 237–246 (1984).
  Article CAS PubMed Google Scholar
• Miranda, T. B. et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 8, 1579–1588 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Knutson, S. K. et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat. Chem. Biol. 8, 890–896 (2012).
  Article CAS PubMed Google Scholar
• Yuan, Y. et al. A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem. Biol. 7, 1152–1157 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vedadi, M. et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol. 7, 566–574 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, P. et al. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Mol. Cancer 14, 55 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393–410 (2011).
  Article CAS PubMed Google Scholar
• Hensley, C. T. et al. Metabolic heterogeneity in human lung tumors. Cell 164, 681–694 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Yuneva, M. O. et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 15, 157–170 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sellers, K. et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J. Clin. Invest. 125, 687–698 (2015).
  Article PubMed PubMed Central Google Scholar
• Cheng, T. et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc. Natl Acad. Sci. USA 108, 8674–8679 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Davidson, S. M. et al. Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer. Cell Metab. 23, 517–528 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Sparmann, A. & van Lohuizen, M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6, 846–856 (2006).
  Article CAS PubMed Google Scholar
• Cao, R. et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039–1043 (2002).
  Article CAS PubMed Google Scholar
• Chang, C. J. et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell 19, 86–100 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gonzalez, M. E. et al. EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc. Natl Acad. Sci. USA 111, 3098–3103 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346–354 (2013).
  Article CAS PubMed Google Scholar
• Conley, S. J. et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc. Natl Acad. Sci. USA 109, 2784–2789 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y., Liu, Y., Malek, S. N., Zheng, P. & Liu, Y. Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8, 399–411 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Muz, B., de la Puente, P., Azab, F., Luderer, M. & Azab, A. K. Hypoxia promotes stem cell-like phenotype in multiple myeloma cells. Blood Cancer J. 4, e262 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L. & Semenza, G. L. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc. Natl Acad. Sci. USA 111, E5429–E5438 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Mao, Q. et al. A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy. J. Cancer Res. Clin. Oncol. 139, 211–222 (2013).
  Article CAS PubMed Google Scholar
• Beck, B. et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478, 399–403 (2011).
  Article CAS PubMed Google Scholar
• Zucchi, I. et al. Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells. Proc. Natl Acad. Sci. USA 105, 16940–16945 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Malanchi, I. et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 452, 650–653 (2008).
  Article CAS PubMed Google Scholar
• Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313–323 (2007).
  Article CAS PubMed Google Scholar
• McCabe, M. T. & Creasy, C. L. EZH2 as a potential target in cancer therapy. Epigenomics 6, 341–351 (2014).
  Article CAS PubMed Google Scholar
• Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311–321 (2005).
  Article CAS PubMed Google Scholar
• Reid, M. A. et al. The B55alpha subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. Mol. Cell 50, 200–211 (2013).
  Article CAS PubMed Google Scholar
• Roberts, E. & Frankel, S. Free amino acids in normal and neoplastic tissues of mice as studied by paper chromatography. Cancer Res. 9, 645–648 (1949).
  CAS PubMed Google Scholar
• Yu, G. et al. Adipogenic differentiation of adipose-derived stem cells. Methods in Mol. Biol. 702, 193–200 (2011).
  Article CAS Google Scholar
• Treweek, J. B. et al. Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping. Nat. Protocols 10, 1860–1896 (2015).
  Article CAS PubMed Google Scholar
• Liu, X., Ser, Z. & Locasale, J. W. Development and quantitative evaluation of a high-resolution metabolomics technology. Analyt. Chem. 86, 2175–2184 (2014).
  Article CAS Google Scholar